Table 4 Treatment by diagnosis results and drug availability
Availability of ACT | Microscopy (blood slide result) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Treatment received | No of patients | % (95% CI) | ACT in stock | % (95% CI) | ACT not in stock | % (95% CI) | p-value | Positive | % (95% CI) | Negative% | % (95% CI) | p-value |
Coartem (ACT) | 154 | 27 (19–35) | 154 | 100 | 0 | n/a | 53 | 32 (20 – 45) | 101 | 26 (17 – 34) | 0.29 | |
Quinine | 131 | 26 (18 – 33) | 73 | 19 (16 – 22) | 58 | 52 (38 – 66) | <0.01 | 46 | 36 (26 – 47) | 85 | 22 (15 – 29) | <0.01 |
Fansidar | 71 | 11 (5 – 17) | 51 | 11 (5 – 17) | 20 | 12 (0.1 – 24) | 0.84 | 16 | 11 (5–19) | 55 | 9 (4 – 14) | 0.17 |
Camoquine | 27 | 5 (2 – 8) | 18 | 5 (1 – 8) | 9 | 6 (3 – 8) | 0.61 | 6 | 4 (2–6) | 21 | 5 (0.1 – 9) | 0.73 |
Chloroquine | 14 | 2 (0.1 – 4) | 12 | 2 (0.3 – 4) | 2 | 1 (-1 – 3) | 0.44 | 4 | 2 (-0.2 – 4) | 10 | 2 (0.4 – 3.6) | 0.95 |
No anti-malarial | 148 | 30 (23 – 37) | 305 | 74 (70 – 78) | 87 | 68 (60 – 76) | 0.20 | 123 | 83 (77 – 90) | 269 | 66 (58 – 73) | <0.01 |
Antibiotic | 151 | 31 (22 – 40) | 105 | 29 (18 – 39) | 46 | 40 (35 – 46) | 0.03 | 43 | 33 (14 – 53) | 108 | 30 (24 – 36) | 0.68 |
Paracetamol | 385 | 69 (61 – 76) | 293 | 68 (60 – 78) | 92 | 70 (61 – 77) | 0.93 | 115 | 78 (64 – 92) | 270 | 65 (59 – 72) | 0.03 |